
Tactile Systems (TCMD) Stock Forecast & Price Target
Tactile Systems (TCMD) Analyst Ratings
Bulls say
Tactile Systems Technology Inc. demonstrated strong growth in its Afflovest product line, achieving $10.7 million in revenue and reflecting a 22% year-over-year increase, driven by successful partnerships with leading durable medical equipment (DME) providers. The company has shown increased confidence in future growth prospects, raising its guidance for the DME segment to a projected growth rate of 20-23% for FY 2025, a notable improvement from the previous forecast of 6-9%. This positive shift in expectations is underscored by the product line's recent performance, which contrasts sharply with the modest 2.8% year-over-year growth experienced in FY 2024, highlighting the potential for significant expansion.
Bears say
Tactile Systems Technology Inc’s financial outlook is negatively impacted by higher-than-expected operating expenses that resulted in an earnings per share miss of -$0.13, which was below analysts' forecasts. The company has revised its fiscal year 2025 revenue guidance down to $309M-$315M from a previous estimate of $316M-$322M, reflecting a slowdown in growth, particularly in its lymphedema business which is now expected to grow by only 4-5%. Additionally, EBITDA expectations for FY 2025 have been lowered to a range of $32M-$34M, down from $35M-$37M, indicating a declining profitability trajectory.
This aggregate rating is based on analysts' research of Tactile Systems and is not a guaranteed prediction by Public.com or investment advice.
Tactile Systems (TCMD) Analyst Forecast & Price Prediction
Start investing in Tactile Systems (TCMD)
Order type
Buy in
Order amount
Est. shares
0 shares